$83.70
▼ -0.0% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Vertex was sole bidder in high-premium Crinetics acquisition
Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
Overview
52-week range
$26
$58
100% of range
Avg surprise (last 3)
-4.9%
Avg reaction (last 2)
+4.2%
100% positive
Latest IV / EM
15%
EM ±3.5% · $85 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-1.23 | $-1.22 | -0.8% | -18.3% | +4.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.38 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-1.23 | $-1.13 | -8.8% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-1.04 | $-0.99 | -5.0% | — | +4.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.96 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.94 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.93 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.01 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.94 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | AMC | -$1.23 | -$1.23 | 0.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $1M | $361,000 | — | — | $399,000 |
| Cost of revenue | $200,000 | — | — | — | $0 | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-140M | — | $-143M | $-129M | $-111M | — | $-88M | $-83M |
| Net income | $-128M | — | $-130M | $-116M | $-97M | — | $-77M | $-74M |
| EPS (diluted) | $-1.23 | — | $-1.38 | $-1.23 | $-1.04 | — | $-0.96 | $-0.94 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $114M | $102M | $111M | $54M | $95M | $265M | $317M | $302M |
| Inventory | $3M | $2M | — | — | — | — | — | — |
| Total current assets | $1.32B | $1.05B | $1.12B | $1.22B | $1.29B | $1.38B | $878M | $875M |
| Total assets | $1.40B | $1.13B | $1.20B | $1.29B | $1.36B | $1.43B | $937M | $936M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $121M | $134M | $124M | $118M | $107M | $110M | $104M | $105M |
| Total equity | $1.28B | $992M | $1.07B | $1.17B | $1.25B | $1.32B | $833M | $831M |